At a conference in Chicago at the end of May oncologists went wild over the results of a drug called daraxonrasib, which ...

From a pancreatic cancer drug that doubles survival to blood tests that may spot tumours years before symptoms appear, ...

Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in lab studies, though long-term safety in humans remains unknown.

Chronic pancreatitis (CP) diminishes quality-of-life (QoL) across mobility, self-care, daily activities, mental health, and pain-not just abdominal discomfort-according to a new Mayo Clinic study ...

In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...

Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made ...

Scientists at the Free University of Brussels (VUB) have taken a major step forward in pancreatic cancer research. By mapping ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Luisa Escobar-Hoyos envisions a world where a pancreatic cancer diagnosis is no longer a death sentence. “Every time I tell people I work on pancreatic cancer, people are like, ‘That’s a really bad ...